The FDA has approved a first-of-its-kind drug to treat moderate to severe hot flashes during menopause.
Veozah is a once-a-day pill to treat moderate to severe hot flashes during menopause.Now, the U.S. Food and Drug Administration has approved a first-of-its-kind drug, fezolinetant, sold under the brand name Veozah, to treat moderate to severe hot flashes during menopause.
According to the FDA, the drug works by targeting the brain's temperature control center to decrease both the frequency and intensity of hot flashes in women. "Hot flashes as a result of menopause can be a serious physical burden on women and impact their quality of life," Dr. Janet Maynard, director of the Office of Rare Diseases, Pediatrics, Urologic and Reproductive Medicine, in the FDA's Center for Drug Evaluation and Research,
Menopause is the point 12 months after a woman's last and final period. The transition to menopause, also known as perimenopause, can take place over the course of several years, which is also how long women can suffer symptoms like hot flashes,Menopause symptoms include everything from the well-known hot flashes and night sweats to the lesser-known and discussed symptoms like anxiety, vaginal dryness, painful intercourse, decrease in sexual function, insomnia and joint pain.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
FDA approves first-of-its-kind drug to treat hot flashesWomen have suffered for centuries with hot flashes, one of the most common symptoms of menopause , without many treatment options.
Lire la suite »
Veozah, a new menopause drug for hot flashes, gets FDA approvalMore than 80% of women experience hot flashes during menopause, the FDA noted.
Lire la suite »
FDA approves first-of-its-kind drug to treat hot flashesWomen have suffered for centuries with hot flashes, one of the most common symptoms of menopause, without many treatment options. Now, the U.S. Food and Drug Administration has approved a first-of-its-kind drug, fezolinetant, sold under the brand name Veozah, to treat moderate to severe hot flashes during menopause. The drug, a pill taken once a day, is hormone-free, which makes it promising for women who cannot take hormone treatment because of other underlying health concerns, such as a prior history of strokes, heart attacks or blood clots.
Lire la suite »
New Once-a-Day Menopause Drug for Hot Flashes Gets FDA ApprovalU.S. health regulators on Friday approved a new type of drug for women dealing with hot flashes caused by menopause.
Lire la suite »
New menopause drug for hot flashes gets FDA approvalThe Food and Drug Administration approved the once-a-day pill from Astellas Pharma to treat moderate-to-severe symptoms, which can include sweating, flushing and chills.
Lire la suite »